A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: Description of two unrelated cases from Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
94
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
OSMAN, Mazen
KIM, Peter W.
Tuyet-Hang Pham
GADINA, Massimo
YANG, Barbara
FERGUSON, Polly J.
Citação
ARTHRITIS AND RHEUMATISM, v.63, n.12, p.4007-4017, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective Monogenic autoinflammatory diseases are disorders of Mendelian inheritance that are characterized by mutations in genes that regulate innate immunity and whose typical features are systemic inflammation without high-titer autoantibodies or antigen-specific T cells. Skin and bone inflammation in the newborn period have been described in 3 of these autoinflammatory disorders: neonatal-onset multisystem inflammatory disease, Majeed syndrome, and deficiency of interleukin-1 (IL-1) receptor antagonist (DIRA) syndrome. This study was undertaken to present the characteristics of the DIRA syndrome in 2 cases from Brazil, and describe a novel mutation in IL1RN. Methods. Two unrelated Brazilian patients were evaluated for the clinical signs and symptoms of these 3 disorders, and peripheral blood samples were assessed for mutations in NLRP3, LPIN2, and IL1RN by DNA resequencing analysis. A mutation in IL1RN that encodes a mutant protein was identified, and the expression and function of this mutant protein were compared to those of the wild-type protein. Results. Both patients presented with pustular dermatitis resembling generalized pustular psoriasis, recurrent multifocal aseptic osteomyelitis, and elevation in the levels of acute-phase reactants, all of which are features most consistent with the DIRA syndrome. Chronic lung disease was observed in 1 of the patients, and jugular venous thrombosis was observed in the other patient. Both patients showed a partial response to corticosteroid therapy, and 1 patient experienced an initial improvement of dermatitis with the use of acitretin. Both patients were homozygous for a novel 15-bp (in-frame) deletion on the IL1RN gene. The mutated protein expressed in vitro had no affinity with the IL-1 receptor, and stimulation of the patients' cells with recombinant human IL-1 alpha or IL-1 alpha led to oversecretion of proinflammatory cytokines, similar to the findings obtained in previously reported patients. Conclusion. The presence of the same homozygous novel mutation in IL1RN in 2 unrelated Brazilian patients suggests that this genetic variant may be a founder mutation that has been introduced in the Brazilian population.
Palavras-chave
Referências
  1. Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688
  2. Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865
  3. Ergin Sibel, 2008, J Dermatolog Treat, V19, P341, DOI 10.1080/09546630802132643
  4. Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357
  5. Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759
  6. Glaser RL, 2008, CURR ALLERGY ASTHM R, V8, P288, DOI 10.1007/s11882-008-0047-1
  7. Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137
  8. Jesus AA, 2008, J CLIN IMMUNOL, V28, P134, DOI 10.1007/s10875-007-9150-7
  9. Majeed HA, 2000, J PEDIATR-US, V137, P441, DOI 10.1067/mpd.2000.107613
  10. MAJEED HA, 1989, J PEDIATR-US, V115, P730, DOI 10.1016/S0022-3476(89)80650-X
  11. Majeed HA, 2001, EUR J PEDIATR, V160, P705, DOI 10.1007/s004310100799
  12. Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627
  13. Prieur AM, 2001, CLIN EXP RHEUMATOL, V19, P103
  14. Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568
  15. Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0
  16. Simon A, 2004, J INTERN MED, V256, P247, DOI 10.1111/j.1365-2796.2004.01359.x
  17. Simon A, 2004, NEUROLOGY, V62, P994, DOI 10.1212/01.WNL.0000115390.33405.F7
  18. Simon A, 2001, ANN INTERN MED, V135, P338, DOI 10.7326/0003-4819-135-5-200109040-00010
  19. Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b
  20. Touitou I, 2008, BEST PRACT RES CL RH, V22, P811, DOI 10.1016/j.berh.2008.08.009